114396-70-2

Basic information

• Product Name: (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid
• Synonyms: (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid
• CAS NO: 114396-70-2
• Molecular Formula: C₁₂H₁₅NO₅
• Molecular Weight: 253.2512
• Mol File: 114396-70-2.mol

Chemical Properties

• Melting Point: 123-126 °C
• Boiling Point: 483.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.313±0.06 g/cm3(Predicted)
• PKA: 3.70±0.11(Predicted)
• CAS DataBase Reference: (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid(114396-70-2)
• EPA Substance Registry System: (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid(114396-70-2)

Safety Data

• Hazardous Substances Data: 114396-70-2(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
(S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid is used as a building block for the synthesis of novel compounds in medicinal chemistry. The benzyloxycarbonyl group protects the amino group, allowing for selective reactions and modifications that can lead to the development of new pharmaceuticals with improved biological properties.
Used in Drug Development:
In the pharmaceutical industry, (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid is used as a precursor for the creation of innovative drug candidates. (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid's unique structure and functional groups can be exploited to design drugs with enhanced efficacy, selectivity, and reduced side effects.
Further research and testing are required to fully explore the potential uses and properties of (S)-2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoic acid, as its complex structure and protective groups may offer new opportunities in the development of therapeutic agents.

Upstream product

• 501-53-1 benzyl chloroformate 
• 114396-62-2 (S)-α-methylserine hydrochloride 
• 212776-40-4 (R)-2-Benzyloxycarbonylamino-2-methyl-malonic acid monoethyl ester 
• 212776-36-8 diethyl 2-(benzyloxycarbonylamino)-2-methylmalonate 
• 3398-40-1 (S)-(+)-2-amino-2-methyl-3-hydroxypropanoic acid 
• 357274-59-0 (S)-methyl 2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoate 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 3005-66-1 diethyl 2-benzyloxycarbonylaminomalonate 

Downstream Products

• 114396-71-3 Z-α-MeSer(OH)-OBzl 
• 357274-59-0 (S)-methyl 2-(benzyloxycarbonylamino)-3-hydroxy-2-methylpropanoate 
• 114396-72-4 Z-α-MeSer(OtBu)-OBzl 
• 1163132-20-4 C₂₂H₂₆N₂O₆ 
• 1163132-29-3 C₂₂H₂₆N₂O₆ 

Relevant articles and documents

Total synthesis and structure elucidation of JBIR-39: A linear hexapeptide possessing piperazic acid and γ-hydroxypiperazic acid residues

The total synthesis and stereochemical structural elucidation of JBIR-39, containing four nonproteinogenic piperazic acid (Piz) residues, is reported. The synthesis includes Sc(OTf)3-catalyzed acylation of a Piz(γ-OTBS) derivative with piperazi

Highly efficient and selective phosphorylation of amino acid derivatives and polyols catalysed by 2-aryl-4-(dimethylamino)pyridine-N-oxides-towards kinase-like reactivity

The chemoselective phosphorylation of hydroxyl containing amino acid derivatives and polyols by phosphoryl chlorides catalyzed by 2-aryl-4-(dimethylamino)pyridine-N-oxides is described.

ORALLY AVAILABLE SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS AND ANTAGONISTS

The present invention relates to S1P analogs that have activity as S1Preceptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds have the general structure (I) wherein R11 is C5-C18 alkyl or C5-C18 alkenyl; Q is selected from the group consisting of C3-C6 optionally substituted cycloalkyl, C3-C6 optionally substituted heterocyclic, C3-C6 optionally substituted aryl C3-C6 optionally substituted heteroaryl and; R2 is selected from the group consisting of H, C1-C4 alkyl, (C1-C4 alkyl)OH and (C1-C4 alkyl)NH2; R23 is H or C1-C4 alkyl, and R15 is a phosphonate ester or a phosphate ester or a pharmaceutically acceptable salt or tautomer thereof.

Chemoenzymatic total synthesis of (+)-conagenin, a low-molecular-weight immunomodulator

Total synthesis of (+)-conagenin, a low-molecular-weight immunomodulator, was achieved based on enantioselective enzymatic reactions followed by chemoselective reductions.

New enantiodivergent procedure for the syntheses of chiral α- substituted serines from α-alkyl-α-aminomalonates utilizing enzymatic hydrolysis

Porcine liver esterase (PLE)- or rabbit liver esterase (RLE)-catalyzed hydrolysis of the pro-S ester group of diethyl α-alkyl-α- (benzyloxycarbonylamino)malonates 2a-c afforded (R)-ethyl α-alkyl-α- (benzyloxycarbonylamino)malonates 3a-c each in excellent enantiomeric excess. Enantiodivergent reductions of these acid esters 3a-c readily furnished both the corresponding enantiomeric α-substituted serines (R)- and (S)-5a-c.